genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Marburg virus
      Drug Discovery

      First-In-Human Trial of Marburg Vaccine Shows Promising Results

      Infectious Disease Diagnostics

      Exploring Ways to Block Malaria Transmission

      measles virus
      Infectious Diseases

      Collective Measles Virus Mutations Linked to Fatal Encephalitis

      Bioprocessing

      Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

      Blood cells
      Infectious Diseases

      Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      blood cells
      Blood Disorders

      Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

      Artificial Intelligence

      Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block

      Antibodies

      Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis

      Bioprocessing

      Cell and Gene Therapy Scale-Up Challenges

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Post-Translational Modifications Page 2

Post-Translational Modifications

  • Glycosylation
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Ribosome, illustration
    eBooks

    Making the Promise of mRNA a Reality: Overcoming Scale-Up Challenges

    Post-Translational Modifications

    Bringing Distributed Manufacturing to the Benchtop

    Manufacture process of vaccine,production of Covid-19 vaccine. Bio science
    Post-Translational Modifications

    Biopharma Will Learn to Embrace Machine Learning

    Bioreactor
    Post-Translational Modifications

    Molecular Code for Lewis X Makes Glycosylation Controllable

    Scientist in a clean room
    Post-Translational Modifications

    In-Process Monitoring System Enables Real-Time Decision-Making

    tobacco field
    Post-Translational Modifications

    Building Therapeutic Proteins through Plant Glycosylation: A Sweet Solution

    NISTmAb monoclonal antibody
    Post-Translational Modifications

    Getting at Glycosylation

    Antibodies
    Post-Translational Modifications

    Optimize Protein Glycosylation—and—Yield by In Vitro Glycoengineering

    Glycosylation enzyme molecule
    Post-Translational Modifications

    Successfully Addressing the Challenges of Glycosylation

    Takeda Pharmeutical lab
    Post-Translational Modifications

    Controlling Product Quality is the Name of the Game for Continuous...

    Post-Translational Modifications

    Potential New Drug Targets ID’ed for Deadly Viruses

    Post-Translational Modifications

    Genetically Encoded Frankenbody Lights Up Live Cell Imaging

    Post-Translational Modifications

    In Pancreatitis and Pancreatic Cancer, a Supposed Bystander May Be a...

    Post-Translational Modifications

    Natural Anti-Parkinson’s Mechanism Discovered That Targets Fibrils, Prevents Lewy Bodies

    A study of acquired heart failure implicates a protein clumping mechanism triggered by a mono-phosphorylated form of desmin. The study also shows that toxic clumping can be detected by positron emission tomography (PET). (Top) A PET scan detects clumping proteins in rat hearts. (Right) The enlarged heart is one with heart failure. (Bottom) Other PET scans showing blood flow in the rat hearts show that the protein clumps aren't due to circulation problems. [Courtesy of Circulation Research
    Post-Translational Modifications

    Alzheimer’s-Like Clumping Proteins Found in Diseased Hearts

    123...5Page 2 of 5

    Recently Featured

    Exploring Ways to Block Malaria Transmission

    Exploring Ways to Block Malaria Transmission

    First-In-Human Trial of Marburg Vaccine Shows Promising Results

    First-In-Human Trial of Marburg Vaccine Shows Promising Results

    Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

    Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Read the Digital Edition

    GEN 2022 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up